We have located links that may give you full text access.
Barriers that impede the safety of medicinal products for children.
Nursing Children and Young People 2011 September 30
The European Paediatric Regulation 2007 was introduced to improve development of high quality medicines for children. A lack of appropriate medicines for this client group is an extensive and well-documented problem and the use of off-label and unlicensed medication is a widespread practice. Ernest et al ( 2007 ) state that most drugs are not labelled, or are inadequately labelled, for use in child patients. Critical safety and efficacy information is lacking and poses significant risks to this vulnerable population.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app